Abstract
Summary
Adrenal function was studied in 6 diabetic patients with hyperglycemia controlled by DBI (N B' phenethylformadinylimourea) or by DBI and insulin. DBI administration did not significantly affect baseline plasma hydrocortisone levels or response to ACTH. These results appear to eliminate adrenal steroid suppression as a possible mode of action of this biguanide.
Get full access to this article
View all access options for this article.
